Buscar

Estamos realizando la búsqueda. Por favor, espere...

Impact of the ENSP eLearning platform on improving knowledge, attitudes and self-efficacy for treating tobacco dependence: An assessment across 15 European countries

Abstract: Introduction: In 2018, the European Network for Smoking Cessation and Prevention (ENSP) released an update to its Tobacco Treatment Guidelines for healthcare professionals, which was the scientific base for the development of an accredited eLearning curriculum to train healthcare professionals, available in 14 languages. The aim of this study was to evaluate the effectiveness of ENSP eLearning curriculum in increasing healthcare professionals' knowledge, attitudes, self-efficacy (perceived behavioral control) and intentions in delivering tobacco treatment interventions in their daily clinical routines. Methods: We conducted a quasi-experimental pre-post design study with 444 healthcare professionals, invited by 20 collaborating institutions from 15 countries (Albania, Armenia, Belgium, Italy, France, Georgia, Greece, Kosovo, Romania, North Macedonia, Russia, Serbia, Slovenia, Spain, Ukraine), which completed the eLearning course between December 2018 and July 2019. Results: Healthcare professionals' self-reported knowledge improved after the completion of each module of the eLearning program. Increases in healthcare professionals' self-efficacy in delivering tobacco treatment interventions (p<0.001) were also documented. Significant improvements were documented in intentions to address tobacco use as a priority, document tobacco use, offer support, provide brief counselling, give written material, discuss available medication, prescribe medication, schedule dedicated appointment to develop a quit plan, and be persistent in addressing tobacco use with the patients (all p<0.001). Conclusions: An evidence-based digital intervention can be effective in improving knowledge, attitudes, self-efficacy and intentions on future delivery of tobacco-treatment interventions.

 Autoría: Girvalaki C., Papadakis S., Mechili E.A., Nikitara K., Demin A., Trofor A.C., Lila A., Harutyunyan A., Saliaj A., Dimitrievska D., Lozano F.R., Bakhturidze G., Ayesta J., Przewozniak K., Cattaruzza M.S., Zdraveska M., Lovše M., Kilibarda B., Stoyka O., Behrakis P., Bizel P., Starchenko P., Spahija S., Radu-Loghin C., Vardavas C.I.,

 Fuente: Tobacco Induced Diseases, 2020, 18(May), 40

 Editorial: BioMed Central

 Año de publicación: 2020

 Nº de páginas: 10

 Tipo de publicación: Artículo de Revista

 DOI: 10.18332/TID/120188

 ISSN: 1617-9625

 Url de la publicación: https://www.doi.org/10.18332/TID/120188

Autoría

GIRVALAKI, CHARIS

PAPADAKIS, SOPHIA

MECHILI, ENKELEINT A

NIKITARA, KATERINA

DEMIN, ANDREY

TROFOR, ANTIGONA C

LILA, ARBEN

HARUTYUNYAN, ARUSYAK

SALIAJ, AURELA

DIMITRIEVSKA, DESKA

LOZANO, FRANCISCO RODRIGUEZ

BAKHTURIDZE, GEORGE

PRZEWOZNIAK, KRZYSZTOF

CATTARUZZA, MARIA SOFIA

ZDRAVESKA, MARIJA

LOVŠE, MIHAELA

KILIBARDA, BILJANA

STOYKA, OTTO

BEHRAKIS, PANAGIOTIS